Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Japan’s top science council has adopted policy recommendations that would permit limited cloning of human embryos for scientific research. An Associated Press story reprinted in the L.A. Times gives the details.

Japan banned human cloning in 2001, but researchers have been allowed to study embryonic stem cells not produced by cloning. The new recommendations would let researchers produce and use cloned human embryos–but only for basic research. The cloned cells won’t be allowed for use in treating human patients, so-called therapeutic cloning. Still, stem cell biologists believe such basic research using cloned stem cells could help them unravel diseases such as cancer, Alzheimer’s, and Parkinson’s.

Britain and South Korea allow therapeutic cloning, while the U.S. prohibits the use of federal funds for any kind of human cloning and is considering laws that would ban it.

0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me